N-Cadherin acts as a predictive biomarker for anti-FGFR therapy in KRAS wild-type NSCLC-MedSci.cn

N-Cadherin acts as a predictive biomarker for anti-FGFR therapy in KRAS wild-type NSCLC

Borrego, SG; Cirauqui, C; Gomez-Sánchez, D; Wang, HY; Luengo, A; Ambrogio, C; Paz-Ares, L; Ferrer, I